Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Whaley

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Behring Institute Mitteilungen|July 1, 1989
Control of immune complexes by the classical pathwayK Whaley, A E Ahmed
Immunology|May 1, 1988
Purification of a plasma protein that inhibits complement-mediated prevention of immune precipitationA E Ahmed, K Whaley
British Journal of Clinical Pharmacology|August 1, 1975
The incidence of antinuclear antibodies in relation to drug therapy in psychiatric patients [proceedings]E C Johnstone, K Whaley
British Journal of Clinical Pharmacology|April 1, 1975
Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysisK Whaley, D J Sloane
Scottish Medical Journal|July 1, 1970
Immunological mechanisms in the pathogenesis of systemic lupus erythematosusK Whaley, W W Buchanan
British Medical Journal|June 28, 1975
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatmentE C Johnstone, K Whaley
British Medical Journal|August 27, 2010
Fatal subaxial dislocation of cervical spine in rheumatoid arthritisK Whaley, W C Dick
The Journal of Rheumatology|July 1, 1980
Alternative pathway complement activation in rheumatoid arthritisA El-Ghobarey, K Whaley
Immunology|December 1, 1978
Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serumK Whaley, R A Thompson
Clinical and Experimental Immunology|September 1, 1982
Prostaglandins and prostaglandin synthetase inhibitors regulate the synthesis of complement components by human monocytesD F Lappin, K Whaley
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Behring Institute Mitteilungen|July 1, 1989
Control of immune complexes by the classical pathwayK Whaley, A E Ahmed
Immunology|May 1, 1988
Purification of a plasma protein that inhibits complement-mediated prevention of immune precipitationA E Ahmed, K Whaley
British Journal of Clinical Pharmacology|August 1, 1975
The incidence of antinuclear antibodies in relation to drug therapy in psychiatric patients [proceedings]E C Johnstone, K Whaley
British Journal of Clinical Pharmacology|April 1, 1975
Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysisK Whaley, D J Sloane
Scottish Medical Journal|July 1, 1970
Immunological mechanisms in the pathogenesis of systemic lupus erythematosusK Whaley, W W Buchanan
British Medical Journal|June 28, 1975
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatmentE C Johnstone, K Whaley
British Medical Journal|August 27, 2010
Fatal subaxial dislocation of cervical spine in rheumatoid arthritisK Whaley, W C Dick
The Journal of Rheumatology|July 1, 1980
Alternative pathway complement activation in rheumatoid arthritisA El-Ghobarey, K Whaley
Immunology|December 1, 1978
Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serumK Whaley, R A Thompson
Clinical and Experimental Immunology|September 1, 1982
Prostaglandins and prostaglandin synthetase inhibitors regulate the synthesis of complement components by human monocytesD F Lappin, K Whaley
Pageof 20